Compare LQDA & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LQDA | CARG |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | 2020 | 2017 |
| Metric | LQDA | CARG |
|---|---|---|
| Price | $37.80 | $37.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $41.00 | $38.32 |
| AVG Volume (30 Days) | ★ 1.1M | 928.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 51.81 | ★ 675.00 |
| EPS | N/A | ★ 1.55 |
| Revenue | $158,320,000.00 | ★ $316,861,000.00 |
| Revenue This Year | $278.87 | $13.89 |
| Revenue Next Year | $57.13 | $8.91 |
| P/E Ratio | ★ N/A | $23.81 |
| Revenue Growth | ★ 1031.18 | 59.92 |
| 52 Week Low | $11.85 | $25.41 |
| 52 Week High | $46.67 | $39.42 |
| Indicator | LQDA | CARG |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 67.50 |
| Support Level | $31.75 | $32.95 |
| Resistance Level | $39.19 | $38.89 |
| Average True Range (ATR) | 2.12 | 1.21 |
| MACD | 0.09 | 0.17 |
| Stochastic Oscillator | 37.52 | 92.82 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.